1 - 6 out of 6Page size: 10
  1. 2022

  2. Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses

    Brinkkemper, M., Veth, T. S., Brouwer, P. J. M., Turner, H., Poniman, M., Burger, J. A., Bouhuijs, J. H., Olijhoek, W., Bontjer, I., Snitselaar, J. L., Caniels, T. G., van der Linden, C. A., Ravichandran, R., Villaudy, J., van der Velden, Y. U., Sliepen, K., van Gils, M. J., Ward, A. B., King, N. P., Heck, A. J. R., & 1 othersSanders, R. W., 22 Dec 2022, In: iScience. 25, 12, 105649.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2021

  4. A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern

    Brinkkemper, M., Brouwer, P. J. M., Maisonnasse, P., Grobben, M., Caniels, T. G., Poniman, M., Burger, J. A., Bontjer, I., Oomen, M., Bouhuijs, J. H., van der Linden, C. A., Villaudy, J., van der Velden, Y. U., Sliepen, K., van Gils, M. J., le Grand, R. & Sanders, R. W., 1 Dec 2021, In: npj Vaccines. 6, 1, 146.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection

    Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre-Bosquet, N., Grobben, M., Claireaux, M., de Gast, M., Marlin, R., Chesnais, V., Diry, S. G., Allen, J. D., Watanabe, Y., Giezen, J. M., Kerster, G., Turner, H. L., van der Straten, K., van der Linden, C. A., Aldon, Y., Naninck, T., Bontjer, I., & 27 othersBurger, J. A., Poniman, M., Mykytyn, A. Z., Okba, N. M. A., Schermer, E. E., van Breemen, M. J., Ravichandran, R., Caniels, T. G., van Schooten, J., Kahlaoui, N., Contreras, V., Lemaître, J., Chapon, C., Fang, R. H. T., Villaudy, J., Sliepen, K., van der Velden, Y. U., Haagmans, B. L., de Bree, G. J., Ginoux, E., Ward, A. B., Crispin, M., King, N. P., van der Werf, S., van Gils, M. J., le Grand, R. & Sanders, R. W., 4 Mar 2021, In: Cell. 184, 5, p. 1188-1200.e19 36 p., 365726.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Engineered miniature H1 promoters with dedicated RNA polymerase II or III activity

    Gao, Z., van der Velden, Y. U., Fan, M., van der Linden, C. A., Vink, M., Herrera-Carrillo, E. & Berkhout, B., 1 Jan 2021, In: Journal of biological chemistry. 296, 100026.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. 2020

  8. Diverse HIV-1 escape pathways from broadly neutralizing antibody PGDM1400 in humanized mice

    van der Velden, Y. U., Villaudy, J., Siteur - van Rijnstra, E., van der Linden, C. A., Vink, M. A., Schermer, E. E., Weijer, K., Berkhout, B., Sanders, R. W. & van Gils, M. J., 1 Jan 2020, In: mAbs. 12, 1, 1845908.

    Research output: Contribution to journal › Article › Academic › peer-review

  9. 2018

  10. Short Communication: Protective Efficacy of Broadly Neutralizing Antibody PGDM1400 Against HIV-1 Challenge in Humanized Mice

    van der Velden, Y. U., Villaudy, J., Siteur-van Rijnstra, E., van der Linden, C. A., Frankin, E., Weijer, K., Schermer, E., Vink, M. A., Berkhout, B., Sanders, R. W. & van Gils, M. J., 2018, In: AIDS research and human retroviruses. 34, 9, p. 790-793

    Research output: Contribution to journal › Article › Academic › peer-review

ID: 4396323